Cardiac function in children with premature ventricular contractions: the effect of omega-3 polyunsaturated fatty acid supplementation

Cardiology in the Young
Taliha OnerVedide Tavli

Abstract

Premature ventricular contractions are accepted as benign in structurally normal hearts. However, reversible cardiomyopathy can sometimes develop. Omega-3 polyunsaturated fatty acids have anti-arrhythmic properties in animals and humans.AimWe evaluated left ventricular function in children with premature ventricular contractions with normal cardiac anatomy and assessed the impact of omega-3 fatty acid supplementation on left ventricular function in a prospective trial. A total of 25 patients with premature ventricular contraction, with more than 2% premature ventricular contractions on 24-hour Holter electrocardiography, and 30 healthy patients were included into study. All patients underwent electrocardiography, left ventricular M-mode echocardiography, and myocardial performance index testing. Patients with premature ventricular contraction were given omega-3 fatty acids at a dose of 1 g/day for 3 months, and control echocardiography and 24-hour Holter electrocardiography were performed. Neither placebo nor omega-3 fatty acids were given to the control group. Compared with the values of the control group, the patients with premature ventricular contraction had significantly lower fractional shortening. The myocardial performa...Continue Reading

References

Jul 27, 1999·Lipids·A LeafG E Billman
Jul 20, 2000·Clinical and Experimental Pharmacology & Physiology·M NishimuraM Yoshimura
Oct 3, 2002·Circulation·Rachel LampertDiwakar Jain
Feb 9, 2005·The American Journal of Clinical Nutrition·Anouk GeelenPeter L Zock
Feb 4, 2006·The Journal of Membrane Biology·A LeafG E Billman
Feb 14, 2006·European Journal of Heart Failure·Kirsten V MikkelsenTorben Haghfelt
Mar 28, 2006·BMJ : British Medical Journal·Lee HooperGeorge Davey Smith
Sep 19, 2007·Journal of Cardiovascular Pharmacology and Therapeutics·Atman Prabodh ShahRobin Yvonne Wachsner
Oct 19, 2007·Journal of Cardiovascular Medicine·Jeppe Hagstrup Christensen, Erik Berg Schmidt
May 8, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Gertie C M Beaufort-KrolMargreet Th E Bink-Boelkens
Mar 27, 2009·The American Journal of Clinical Nutrition·Patrick J SmithLana L Watkins
Aug 20, 2009·Mini Reviews in Medicinal Chemistry·Pawel Petkow Dimitrow, Marek Jawien
Nov 24, 2011·Frontiers in Physiology·Jeppe Hagstrup Christensen
Nov 1, 2016·Current Cardiology Reports·Rachel Lampert

❮ Previous
Next ❯

Citations

Jul 10, 2019·Cardiology in the Young·Reiner Buchhorn, Christian Willaschek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.